Management of Blood in Cough

Bronchial Artery Embolization in the Management of Hemoptysis - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065635

Enrollment

Registered

2024-04-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J398- Other specified diseases of upperrespiratory tract Health Condition 2: J42- Unspecified chronic bronchitis

Interventions

Intervention1: Bronchial artery embolization: Embolization of the bronchial artery by PVA particles in cases of hemoptysis Dose- 2-5 cc Frequency- 1-2 minutes during the procedure Route of administra

Eligibility

Inclusion criteria

Inclusion criteria: 1. The potential candidate for BAE is a patient meeting any of the following criteria: 2. Hemoptysis >200ml /h or 600 ml /24 hrs 3. Hypovolemia due to acute Hemoptysis with systolic BP 90 mm hg. 4. Respiratory failure due to acute Hemoptysis requiring endotracheal intubation and mechanical ventilation.

Exclusion criteria

Exclusion criteria: 1. Patients not giving consent for the procedure. 2. Patients having deranged coagulation profile. 3. Patients declared unfit on pre-anaesthetic checkups due to co-morbidities 4. Pregnant patients. 5. Allergic to contrast media 6. Deranged KFT

Design outcomes

Primary

Measure	Time frame
Clinical improvement of symptomsTimepoint: 1 month 6 months	—

Secondary

Measure	Time frame
NATimepoint: NA	—

Countries

India

Contacts

Public ContactPankaj Banode

Department of Interventional Radiology Sawangi Meghe Wardha Maharashtra 442004

drpjbanode@gmail.com8885481235

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026